Skip to main content
. 2023 Mar 6;98(3):331–338. doi: 10.1016/j.abd.2022.05.005

Table 4.

Frequency distribution of clinical data related to the result of the ML Flow serological test in leprosy cases (n = 26).

Clinical data of cases ML Flow cases
Total p-valuea
Positive
Negative
n % n % n (%)
Clinical form Indeterminate 1 3.8 1 (3.8) 0.01
Tuberculoid 3 11.5 3 (11.5)
Borderline 4 15.4 1 3.8 5 (19.2)
Lepromatous 10 38.5 7 27.0 16 (65.5)
Bacilloscopy Positive 12 46.1 4 15.4 16 (61.5) 0.00
Negative 2 7.7 8 30.8 10 (38.5)
Biopsy b Suggestive of leprosy 5 41.7 5 41.7 10 (83.4) 0.31
Negative 2 16.6 2 (16.6)
Degree of disability With DPD 5 19.2 4 15.4 9 (34.6) 0.61
Without DPD 9 34.6 8 30.8 17 (65.4)
Operational classification Paucibacillary 5 19.2 5 (19.2) 0.01
Multibacillary 14 53.8 7 27.0 21 (80.8)

DPD, Degree of Physical Disability, according to the World Health Organization.

a

Fishers' exact test.

b

14 cases had no information about the biopsy in their medical records.